"When in doubt, use Haloperidol." Or not?
DOI:
https://doi.org/10.19230/jonnpr.3011Keywords:
-Abstract
-Downloads
References
Oransky I. Paul Janssen (Obituary). The Lancet 2004;363:251.
Medrano J. Boticarium. Rev Asoc EspNeuropsiq2014;34:175-194.
Girard TD, Exline MC, Carson SS, Hough CL, Rock P, Gong MN, et al. Haloperidol and Ziprasidone for treatmentof delirium in critical illness. NEnglJMed 2018;379;2506-16.
López-Muñoz F, Alamo C. The consolidation of neuroleptic therapy: Janssen, the discovery of haloperidol and its introduction into clinical practice. Brain Res Bull 2009; 79:130-41.
Latronico N. Haloperidol and delirium in the ICU: thefinger pointing to the moon. Intensive Care Med 2018;44:1346-48.
Markowitz JD, NarasimhanM. Delirium and antipsychotics:A systematic review of epidemiology and somatic treatment options. Psychiatry (Edgemont) 2008;5:29-36.
European Delirium Association y American Delirium Society. The DSM- 5 criteria, level of arousal and delirium diagnosis: inclusiveness is safer. BMC Medicine 2014;12:141.
Shen Y. · Peng K. · Zhang J. · Meng X. · Ji F. Effects of Haloperidol on Delirium in Adult Patients: A Systematic Review and Meta-Analysis. Med Princ Pract 2018;27:250–259 https://doi.org/10.1159/000488243
Bleck TP. Dopamine antagonists in ICU delirium. NEnglJMed 2018;379;2569-70.
Published
Issue
Section
License
All accepted originals remain the property of JONNPR. In the event of publication, the authors exclusively transfer their rights of reproduction, distribution, translation and public communication (by any sound, audiovisual or electronic medium or format) of their work. To do so, the authors shall sign a letter transferring these rights when sending the paper via the online manuscript management system.
The articles published in the journal are freely used under the terms of the Creative Commons BY NC SA license, therefore.
You are free to:
Share — copy and redistribute the material in any medium or format
Adapt — remix, transform, and build upon the material
The licensor cannot revoke these freedoms as long as you follow the license terms.
Under the following terms:
Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
NonCommercial — You may not use the material for commercial purposes.
ShareAlike — If you remix, transform, or build upon the material, you must distribute your contributions under the same license as the original.
No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License